What is the Ferriman‑Gallwey (FG) score, how is it calculated across the nine body areas, and what total score indicates hirsutism in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ferriman-Gallwey Score

The Ferriman-Gallwey (FG) score is a visual assessment tool that evaluates terminal hair growth across nine androgen-sensitive body areas, with a total score ≥8 indicating hirsutism in most populations, though this threshold varies by ethnicity. 1

How the Score is Calculated

The modified Ferriman-Gallwey (mFG) scoring system evaluates terminal (coarse) hair growth in nine specific body areas:

  • Upper lip
  • Chin
  • Chest
  • Upper abdomen
  • Lower abdomen
  • Upper arms
  • Thighs
  • Upper back
  • Lower back

Each area is scored from 0 to 4:

  • 0 = No terminal hair
  • 1 = Minimal terminal hair
  • 2 = More than minimal but less than complete coverage
  • 3 = Complete coverage, light density
  • 4 = Complete coverage, heavy density

The scores from all nine areas are summed to produce a total score ranging from 0 to 36. 1

Diagnostic Threshold for Hirsutism

A total mFG score ≥8 defines hirsutism in European and North American populations 1. The Endocrine Society guidelines classify severity as:

  • Mild hirsutism: Score 8-15
  • Moderate to severe hirsutism: Score >15 1

Critical Ethnic Considerations

The cutoff score of ≥8 is NOT universally applicable and must be adjusted for ethnicity:

  • Asian populations: Even mild hirsutism may indicate androgen excess; lower thresholds should be considered 1
  • South Asian populations: A cutoff of ≥5 has been proposed 2
  • Latin American populations: A cutoff of ≥6 may be more appropriate 3
  • Chinese populations: A cutoff of ≥2 has been suggested 4

Practical Clinical Application

Key Body Areas for Screening

The chin, lower abdomen, and thighs are the most clinically relevant areas for detecting hirsutism 5, 6. Research demonstrates:

  • Terminal hair was present on the chin in 97.4%, thighs in 96.5%, and lower abdomen in 92.1% of hirsute women 5
  • Evaluating just the chin, upper abdomen, and lower abdomen accurately predicts total body hirsutism and distinguishes hirsute from non-hirsute women 6

This simplified approach is particularly useful when full-body examination is impractical.

Important Clinical Caveats

The mFG score has significant limitations in clinical practice 1:

  1. Most women use cosmetic hair removal before medical consultation, making accurate scoring impossible
  2. The score does not correlate well with androgen levels due to variable follicular response to androgens 1
  3. Treatment decisions should prioritize patient distress rather than absolute score values 1

When to Investigate Further

Testing for androgen excess is NOT recommended for isolated mild hirsutism (score 8-15) with regular menses, as the likelihood of finding a treatable disorder is low 1.

DO test for elevated androgens when:

  • mFG score >15 (moderate to severe hirsutism)
  • Sudden onset or rapid progression
  • Associated virilization (clitoromegaly, increased muscularity)
  • Menstrual irregularity, infertility, or other PCOS features
  • Abdominal or pelvic mass 1

Alternative Assessment Methods

Image-based mFG scoring using mobile phone photographs shows acceptable concordance with in-person evaluation (agreement 0.89), offering a valid alternative for telemedicine or pandemic conditions 7. Images should be acquired under standardized lighting conditions of all nine body areas.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.